UK diabetes projects receive Sanofi funding

Global healthcare firm Sanofi has pledged its support for three UK diabetes initiatives that focus on a wide range of people affected by type 1 and type 2 diabetes .
Sanofi Diabetes announced a £10,000 donation to help fund the Diabetes UK projects last week at the charity group’s annual professional conference in Manchester.
The first project focuses on Diabetes UK Children and Young People’s Events, which offer children with type 1 diabetes the opportunity to socialise and learn about living with the disease from others of a similar age. The fun-filled initiative is designed to help kids develop a positive attitude and become confident in managing their diabetes .
The second project is called Family Events and is aimed at helping parents who have a child with type 1 diabetes form friendships and gain support from other people in the same situation. Parents attend relaxed supportive and informative discussion groups covering a range of topics as hypoglycemia (low blood sugar), healthy eating choices and emotional care, while children (including non-diabetic siblings) spend the day enjoying fun activities and educational sessions.
The third project is based on producing type 2 diabetes awareness films for Black, Asian and Minority Ethnic (BAME) communities. Each film will highlight the importance of being aware of type 2 diabetes and its risk factors, as well as how to reduce the risk of developing the metabolic condition.
Caroline Horwood, diabetes division director at Sanofi Diabetes, said: “Sanofi Diabetes is committed to supporting people with diabetes, as well as their families, by providing information, assistance and opportunities to share emotional and practical experiences of living with diabetes through engaging and worthy initiatives such as these with Diabetes UK. We look forward to seeing how our funding helps to deliver these three projects.”
Barbara Young, chief executive of Diabetes UK, commented: “These are three very valuable projects that all have the potential to make a real difference to people with both Type 1 and Type 2 diabetes, or at risk of developing Type 2 diabetes . We are extremely grateful for Sanofi’s support for them.”